Rita Frangiamore

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Zilucoplan as a rescue therapy in myasthenic crisis: a case description and summary of early report experiences.

Zilucoplan as a rescue therapy in myasthenic crisis: a case description and summary of early report experiences.

Journal: Acta neurologica Belgica
Published: March 01, 2026

Disease changes and cost analysis of myasthenia gravis: a 10 years retrospective study from a reference center in Italy.

Disease changes and cost analysis of myasthenia gravis: a 10 years retrospective study from a reference center in Italy.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: January 30, 2026

Considerations on comorbidity, chronic intravenous immunoglobulins, and methodological clarifications on ZILU25 study.

Considerations on comorbidity, chronic intravenous immunoglobulins, and methodological clarifications on ZILU25 study.

Journal: Journal of the neurological sciences
Published: January 18, 2026

Enhanced antibody detection via live cell-based assay among RIA negative myasthenia gravis patients: toward improved diagnosis and clinical correlates.

Enhanced antibody detection via live cell-based assay among RIA negative myasthenia gravis patients: toward improved diagnosis and clinical correlates.

Journal: Journal of neurology
Published: January 16, 2026

Authors' reply to comment letter on ZILU25 study.

Authors' reply to comment letter on ZILU25 study.

Journal: Journal of the neurological sciences
Published: January 13, 2026

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Journal: Journal of the neurological sciences
Published: October 06, 2025

Does myasthenia gravis impact cognitive functioning? A systematic review and meta-analysis.

Does myasthenia gravis impact cognitive functioning? A systematic review and meta-analysis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: September 01, 2025

Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction.

Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 31, 2025

Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience.

Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: November 24, 2024

Efgartigimod improves triple-negative myasthenia gravis.

Efgartigimod improves triple-negative myasthenia gravis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: September 15, 2023

Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center.

Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center.

Journal: European journal of neurology
Published: June 06, 2023

Concordance between patient- and physician-reported Myasthenia Gravis Activities of Daily Living (MG-ADL) scores.

Concordance between patient- and physician-reported Myasthenia Gravis Activities of Daily Living (MG-ADL) scores.

Journal: Muscle & nerve
Published: October 28, 2022
Showing 1-12 of 33

Last Updated: 09/26/2026